How Zimmer Biomet Holdings (ZBH) Makes Money: A Visual Guide
Zimmer Biomet Holdings (ZBH) generated $8.23B in revenue (TTM through Q4 2025), earning $705.20M in net profit (8.6% margin). Its largest revenue source is Knees (42.2% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.
Zimmer Biomet Holdings (ZBH) Income Statement Flow
Frequently asked questions
How does Zimmer Biomet Holdings (ZBH) make money?
- Zimmer Biomet Holdings (ZBH) primarily makes money through Knees, which accounts for 42.2% of total revenue. For TTM through Q4 2025, Zimmer Biomet Holdings generated $8.23B in total revenue with a net profit margin of 8.6%.
What is Zimmer Biomet Holdings (ZBH) gross profit margin?
- Zimmer Biomet Holdings (ZBH) reported a gross profit margin of 69.7% for TTM through Q4 2025, equivalent to $5.74B in gross profit. This means Zimmer Biomet Holdings retains 69.7% of each revenue unit after direct costs of production.
What is Zimmer Biomet Holdings (ZBH) operating profit margin?
- Zimmer Biomet Holdings (ZBH) reported an operating profit margin of 15% for TTM through Q4 2025, equivalent to $1.23B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Zimmer Biomet Holdings (ZBH) net profit margin?
- Zimmer Biomet Holdings (ZBH) reported a net profit margin of 8.6% for TTM through Q4 2025, equivalent to $705.20M in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Zimmer Biomet Holdings (ZBH) invest in R&D?
- Zimmer Biomet Holdings (ZBH) invested $458.60M in research and development in TTM through Q4 2025 (5.6% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Zimmer Biomet Holdings (ZBH) spend on capital expenditures?
- Zimmer Biomet Holdings (ZBH) spent $405.60M on capital expenditures in TTM through Q4 2025 (4.9% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Zimmer Biomet Holdings (ZBH) free cash flow?
- Zimmer Biomet Holdings (ZBH) generated $1.85B in free cash flow for TTM through Q4 2025 (22.5% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Zimmer Biomet Holdings (ZBH) effective tax rate?
- Zimmer Biomet Holdings (ZBH) had an effective tax rate of 15.1% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.
About this data
- What is a Sankey diagram?
- A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
- How is the data calculated?
- We use the income statement from company filings. For TTM (Trailing Twelve Months), we sum the last four quarters. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
- When was this data last updated?
- Based on company filings through TTM through Q4 2025.